Notice of Board of Director and Corporate Auditor Nominations
May 1, 2025, Osaka, Japan - Santen Pharmaceutical Co., Ltd. (hereinafter Santen) at a Board of Directors meeting held May 1, 2025, resolved to propose the following candidates of the Board of Directors, which will be submitted for approval at the 113th Annual General Meeting of Shareholders and the Board of Directors to be held in June 2025. Please note that no changes to Corporate Auditors have been proposed.
Members of the Board of Directors (After the 113th Annual General Meeting of Shareholders scheduled to be held in June 2025)
[Directors]
| Name | New position | Current position | |
|---|---|---|---|
| Reappointed | Takeshi Ito | Representative Director of the Board, President, Chief Executive Officer | Representative Director of the Board, President, Chief Executive Officer |
| Rie Nakajima | Member of the Board, Corporate Officer Chief Operating Officer | Member of the Board, Corporate Officer Chief Operating Officer | |
| Ippei Kurihara | Member of the Board, Corporate Officer Head of Japan Business Global Commercial Strategy | Member of the Board, Corporate Officer Head of Japan Business Global Commercial Strategy | |
| Masahiko Ikaga | Member of the Board* | Member of the Board* | |
| Minoru Kikuoka | Member of the Board* | Member of the Board* | |
| Newly appointed | Yukiko Kuroda | Member of the Board* | --- |
| Retirement | Akira Kurokawa | --- | Director of the Board, Chairman |
| Noboru Kotani | --- | Member of the Board* | |
| Tamie Minami | --- | Member of the Board* |
*Outside Directors and independent officers as designated by the Tokyo Stock Exchange
About Santen
As a specialized company dedicated to eye health, Santen aspires to contribute to the realization of “Happiness with Vision” by providing products and services to patients, consumers, and medical professionals around the world. Since its establishment, and guided by its CORE PRINCIPLE, “Tenki ni sanyo suru,” Santen has been committed to helping people maintain and improve their eye health for more than 130 years. Santen is engaged in the global research and development, manufacturing, and sales and marketing of pharmaceutical products in the field of eye care, supporting the eye health of approximately 50 million people in more than 60 countries and regions worldwide. Santen’s mission is to provide essential and significant value to patients and society in the prevention, diagnosis, and treatment of eye diseases through products and services created from its expertise in the ophthalmology field and from the patient's perspective. To create a future in which as many patients as possible can lead happy and fulfilling lives, Santen is committed to doing its utmost to realize a society in which people around the world can experience “Happiness with Vision.”
For more information, please visit Santen’s website https://www.santen.com/en.
Contact
Corporate Communications
Santen Pharmaceutical Co., Ltd.
E-mail: communication@santen.com
Official SNS
